top of page

Search Results

Results found for "Jana Selent"

  • Ross Cheloha: Nanobody-GPCR Conjugates and the Engineering of Receptor Selectivity | Dr. GPCR Ecosystem

    Cheloha builds nanobody-GPCR ligand conjugates that rescue weak peptides, engineer receptor selectivity And can selectivity for one receptor subtype be engineered without redesigning the ligand from scratch Conformation selectivity changes the duration of the signal PTH receptor exists in G-protein coupled Attaching a short PTH fragment to a PTHR1-selective nanobody produces a ligand selective for that subtype ; the same fragment attached to a PTHR2-selective nanobody redirects it entirely.

  • Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem

    Hay on class B GPCRs, RAMPs, and the selectivity problem in CGRP-targeted migraine therapies - what the The Erenumab Selectivity Problem Erenumab, the first monoclonal antibody approved against a GPCR complex are conformational and fine-grained, not structurally obvious, making ligand selectivity considerably , selective ligands, and bimolecular fluorescence complementation in vivo 26:42 Structural data and what Because we don't have selective ligands."

  • Dr. John Streicher: Reorganizing Opioid Signaling Beyond the Receptor | Dr. GPCR Ecosystem

    John Streicher on how HSP90 flips direction between brain and spinal cord, why isoform-selective inhibitors Current lines of work include isoform-selective HSP90 inhibition as a strategy for widening the opioid The "brain always wins" problem is solved by isoform selectivity, not by dose. With a non-selective HSP90 inhibitor given systemically, the brain effect dominates and pain relief is The route from "intrathecal only" to "oral pill" runs through isoform selectivity.

  • Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem

    Pfleger challenges a silent assumption embedded in most of them: that the time point chosen for each Understanding receptor complexes is where the next layer of selectivity and specificity in drug discovery with angiotensin and CCR2 receptors in cell-based systems, working through the logic of functional selectivity 32:26 Screening receptors in complexes, not in isolation 40:03 When cell biology reached the patient Selected

  • Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem

    Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates Turning functional selectivity This phenomenon, receptor signaling bias or functional selectivity, is now recognized as a meaningful detect and quantify it using reliable functional assays, and discusses how these data can guide lead selection explanations of biased signaling and co-authored the widely-applied simple method for quantifying functional selectivity

  • Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem

    And yet approved therapies that selectively target these receptors remain remarkably scarce. One reason is that selectivity in this family is not just a matter of receptor subtype. subtype pharmacology - the four subtypes, their G protein coupling profiles, and why ubiquity creates selectivity Comeo's work uses selective antagonist controls and NanoBRET-tagged receptor constructs to distinguish collaboration, and not fearing the unknown 54:44 The dopamine rush that keeps scientists coming back SELECTED

  • Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem

    frizzled subtypes, receptor conformational dynamics, and biosensor platforms for quantifying signaling selectivity — how the receptor may choose between disheveled and G-protein signaling through conformational selection Disheveled may regulate access to both G-protein and beta-catenin pathways through conformational selection Schulte's lab has preliminary evidence that disheveled undergoes conformational selection at the receptor strongest argument for GPCR identity 01:03:11 Career advice: explore widely, then commit to a niche Selected

  • Dr. Robert F. Bruns | Dr. GPCR Ecosystem

    He taught himself chemoinformatics as a way to optimize compound selection for screening, and in 1997 He supported the D1 PAM project in various roles from its inception in 2002 until selection of a clinical

  • Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem

    Her work has also explored receptor subtype selectivity and peptide-binding GPCRs, connecting structural Subtype Selectivity Emerges from Subtle Structural Differences Even closely related receptor subtypes Selected Quotes “Communication pathways connect the ligand-binding site to the intracellular signaling Applications to Receptor Selectivity Dr. Nivedha: After that, I extended this work to study subtype selectivity.

  • Dr. Lauren M. Slosky | Dr. GPCR Ecosystem

    linking distinct signaling pathways with their physiological effects and may serve as the basis for more selective the Slosky Lab is now working to understand how the principles of receptor allosterism and functional selectivity

  • Yao Lu (Jackie) | Dr. GPCR Ecosystem

    ) "Jackie is a Ph.D. student, at Monash University, Australia, investigating the role of functional selectivity

  • Irfan Dhanidina, Dr. Kathleen Caron and Dr. Lauren Slosky | Dr. GPCR Ecosystem

    role at Orion Biotechnology, I work at the intersection of science and business, which includes target selection linking distinct signaling pathways with their physiological effects and may serve as the basis for more selective the Slosky Lab is now working to understand how the principles of receptor allosterism and functional selectivity

  • Foundry for GPCR Organizations | Dr. GPCR Ecosystem

    . 👉 Book a Free 30-min Strategy Call Select your Challenge... ↑ Pick your challenge to see tailored into practical understanding you can apply to data interpretation, lead optimization, and candidate selection

  • Foord: Serendipity, RAMPs, And Industrial GPCR Pharmacology | Dr. GPCR Ecosystem

    the challenges of target validation, and the realities of industrial decision-making around receptor selectivity Drug Discovery Is Constrained by Selectivity, Safety, and Strategy . the CRLR binding pocket is shared across CGRP, amylin, and adrenomedullin receptors, small-molecule selectivity CRLR signaling. 18:00 — Industrial migraine programs, small-molecule CGRP antagonists, challenges with selectivity

  • GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem

    What learning from “failed” screens can reveal about receptor pharmacology and species selectivity. industrial postdoctoral fellowship at GSK, where he entered the GPCR field and became proficient in aptamer selection

  • Qing Fan: Inside the Architecture of Class C GPCRs | Dr. GPCR Ecosystem

    Baclofen, a selective GABA-B agonist, is the only FDA-approved drug targeting this receptor. work on the mu opioid receptor by Kobilka, Gnäder, Roth, and Shokat as an illustration of what pathway-selective She acknowledges the field's more recent reassessment of how clean that selectivity actually is in vivo - Increasing diversity in science through mentorship, structured Q&A, and institutional commitment SELECTED And this feature opens more room for selecting a specific effect without also interfering with other

  • Kathryn Livingston: Allosteric Opioid Modulators and Receptor Signaling Beyond the Membrane | Dr. GPCR Ecosystem

    Livingston's PhD research at the University of Michigan addressed this systematically - mapping selectivity investigated the first allosteric modulators of opioid receptors under Traynor, characterizing their selectivity Scientific Themes of the Conversation Allosteric modulation of opioid receptors - mechanism, selectivity 58 What both roles look like day-to-day 39:28 Three steps for PhDs and postdocs considering industry Selected

  • Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem

    Scientific Themes of the Conversation Chemokine receptor redundancy and the shift toward functional selectivity binding CCR2B showed the opposite: distinct ligands activate distinct signaling outputs, and functional selectivity 09:00 A master's, old-school molecular biology, and an accelerated JBC paper 11:00 CCR2B, functional selectivity , funding, and what's next 46:53 Recording Brian Roth from a Prius — the closet-studio origin story Selected

  • Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem

    week Structural insights into prolactin-releasing peptide receptor signaling and G-protein coupling selectivity equilibrioception GPCR Activation and Signaling Extensive location bias of the GPCR-dependent translatome via site-selective Function Structural insights into prolactin-releasing peptide receptor signaling and G-protein coupling selectivity

  • Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem

    Attendees will gain a technical understanding of probe design, selectivity, and validated applications The company's portfolio is built around high-affinity, selective fluorescent ligands for GPCRs, supporting

  • Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem

    concept for rescuing misfolded GPCR mutants, and biosensor platforms that helped establish functional selectivity living cells Pharmacological chaperones and the concept of rescuing misfolded receptors Functional selectivity Every receptor his lab has studied was selected because it was the right model for a question that was mutations 40:19 Advice for junior scientists and the rewards of discovery 43:41 Closing reflections SELECTED

  • Maria Waldhoer: Pharmacological Fingerprints and the Limits of Bias | Dr. GPCR Ecosystem

    The approach sits in deliberate tension with the prevailing vocabulary of bias factors and functional selectivity Functional selectivity has been in the vocabulary since her PhD years in Vienna. including the EU grant pitch in Brussels 01:01:53 — "You're only as good as the other people you're with" Selected

  • Dylan Eiger | Dr. GPCR Ecosystem

    phosphorylation (phosphorylation barcodes) and subcellular GPCR signaling in directing functionally selective

  • Dr. Graeme Milligan | Dr. GPCR Ecosystem

    His experience also includes translating knowledge generated into the selection of targets, screening

  • Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem

    He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and

  • Yamina's Corner | Dr. GPCR Ecosystem

    Insights: Translate complex GPCR pharmacology into clear decisions for lead optimization and candidate selection Together, we clarify specific, measurable goals, from target validation and assay development to CRO selection Whether it's optimizing CRO selection, building robust internal capabilities, or translating complex

  • GPCR Retreat | Dr. GPCR Ecosystem

    Additionally, each symposium of the GPCR Retreat 2023 will include one trainee short talk selected from encouraged to register to the meeting and submit an abstract for consideration for the trainee symposia and selected

  • Terry Hebert: How Cellular Background and Localization Influence GPCR Function | Dr. GPCR Ecosystem

    membranes represent an untapped pharmacological frontier, and caged ligands offer a route to drugging them selectively lab developed caged ligands that cross the plasma membrane and are uncaged intracellularly, enabling selective moments that reshaped a career: dimers, nuclear GPCRs, and G-proteins as transcriptional regulators Selected

  • Dr. Bianca Plouffe | Dr. GPCR Ecosystem

    involved in the angiotensin type 2 receptor (AT2R)-mediated neurite outgrowth while characterizing new selective

  • Dr. Prasenjit Saha | Dr. GPCR Ecosystem

    modulators has gained attention as they have the potential to fine-tune cellular responses with greater selectivity

bottom of page